Scarica l'app Stockscreener
0.3458
7.18%
-0.022
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GBIO Giù?
Forum
Previsione
Precedente Chiudi:
$0.3678
Aprire:
$0.36
Volume 24 ore:
344.19K
Relative Volume:
0.68
Capitalizzazione di mercato:
$23.86M
Reddito:
-
Utile/perdita netta:
$-126.61M
Rapporto P/E:
-0.1764
EPS:
-1.96
Flusso di cassa netto:
$-60.14M
1 W Prestazione:
-8.35%
1M Prestazione:
-28.88%
6M Prestazione:
-86.12%
1 anno Prestazione:
-89.09%
Intervallo 1D:
$0.3349
$0.37
Intervallo di 1 settimana:
$0.3331
$0.40
Portata 52W:
$0.316
$4.34
Generation Bio Co Stock (GBIO) Company Profile
Nome
Generation Bio Co
Settore
Industria
Telefono
857-529-5908
Indirizzo
301 BINNEY STREET, CAMBRIDGE
Confronta GBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.3447 | 23.86M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.67 | 126.49B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
546.85 | 59.71B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
586.59 | 36.26B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.26 | 29.48B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
227.91 | 25.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-10-19 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-24 | Iniziato | William Blair | Outperform |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-07-07 | Iniziato | Cowen | Outperform |
| 2020-07-07 | Iniziato | JP Morgan | Overweight |
| 2020-07-07 | Iniziato | Jefferies | Buy |
| 2020-07-07 | Iniziato | Wedbush | Outperform |
Mostra tutto
Generation Bio Co Borsa (GBIO) Ultime notizie
Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World
GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia
GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times
Generation Bio Takes Center Stage: CEO Fireside Chat at Major Healthcare Conference - Stock Titan
Generation Bio stock hits 52-week low at $0.4 amid steep decline By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Cuts Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates - MSN
Generation Bio stock hits 52-week low at $0.47 By Investing.com - Investing.com South Africa
Generation Bio stock hits 52-week low at $0.47 - Investing.com India
Generation Bio’s (GBIO) Buy Rating Reaffirmed at Canaccord Genuity Group - Defense World
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution By Investing.com - Investing.com South Africa
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution - Investing.com Australia
Generation Bio’s (GBIO) Outperform Rating Reiterated at Wedbush - Defense World
Generation Bio Co. (NASDAQ:GBIO) Not Doing Enough For Some Investors As Its Shares Slump 29% - Simply Wall St
Generation Bio Co. Advances in Autoimmune Therapeutics - TipRanks
Generation Bio Co reports results for the quarter ended December 31Earnings Summary - TradingView
Generation Bio stock holds Market Perform rating at JMP - Investing.com India
Generation Bio stock holds Market Perform rating at JMP By Investing.com - Investing.com UK
Generation Bio earnings missed by $0.02, revenue topped estimates - Investing.com South Africa
Generation Bio Co (GBIO) Q4 2024 Earnings: EPS Misses Estimate o - GuruFocus.com
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position - Nasdaq
Generation Bio's Breakthrough: 98% T Cell Success Powers $185M Cash Runway Through 2027 - StockTitan
Generation Bio Co (GBIO)’s stock rises to 0.52 per share - US Post News
Generation Bio stock hits 52-week low at $0.52 By Investing.com - Investing.com Australia
A Guide To The Risks Of Investing In Generation Bio Co (GBIO) - Knox Daily
Generation Bio stock hits 52-week low at $0.52 - Investing.com
Generation Bio (GBIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Contrasting Generation Bio (NASDAQ:GBIO) & Anthera Pharmaceuticals (OTCMKTS:ANTH) - Defense World
Generation Bio faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Generation Bio faces Nasdaq delisting over share price - Investing.com
Generation Bio Co Azioni (GBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Generation Bio Co Azioni (GBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. | Director |
Jan 13 '25 |
Buy |
0.97 |
85,000 |
82,450 |
299,286 |
| Howze Yalonda | CHIEF LEGAL OFFICER |
Oct 15 '24 |
Option Exercise |
2.42 |
3,347 |
8,100 |
15,169 |
| Paone Antoinette | CHIEF OPERATING OFFICER |
Jul 01 '24 |
Sale |
2.74 |
6,719 |
18,410 |
13,807 |
1.19%
2.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):